Literature DB >> 15571250

Immucillins as antibiotics for T-cell proliferation and malaria.

Vern L Schramm1.   

Abstract

The genetic deficiency of human PNP causes a specific immunodeficiency by inducing apoptosis in dividing T-cells. Powerful inhibitors of PNP have been designed from the experimental determination of the transition state structure of PNPs. The Immucillins are transition state analogue inhibitors with Kd values as low as 7 pM. In the presence of deoxyguanosine the Immucillins kill activated human T-cells but not other cell types. The Immucillins are orally available and of low toxicity to mice. Immucillins also inhibit PNP from Plasmodium falciparum. Parasites cultured in human erythrocytes are killed by purine starvation in the presence of Immucillins and can be rescued by hypoxanthine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571250     DOI: 10.1081/NCN-200027564

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  4 in total

1.  Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).

Authors:  Paul M Riegelhaupt; I J Frame; Myles H Akabas
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

Review 2.  Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum.

Authors:  Megan J Downie; Kiaran Kirk; Choukri Ben Mamoun
Journal:  Eukaryot Cell       Date:  2008-06-20

3.  Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.

Authors:  Min Huang; Yanhong Wang; Jingjin Gu; Jing Yang; Karen Noel; Beverly S Mitchell; Vern L Schramm; Lee M Graves
Journal:  Leuk Res       Date:  2008-02-14       Impact factor: 3.156

4.  Purine nucleoside phosphorylase from Schistosoma mansoni in complex with ribose-1-phosphate.

Authors:  Humberto D'Muniz Pereira; Glaucius Oliva; Richard Charles Garratt
Journal:  J Synchrotron Radiat       Date:  2010-11-12       Impact factor: 2.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.